Search Results for 'biotech'

Search For:
Refine by Dates:
From: To:
Refine By Content:

  • Sartorius Stedim Biotech Adds Single-Use Bioreactors

    May 12, 2009
    Sartorius Stedim Biotech expanded its technology portfolio with the addition of two prototypes of single-use bioreactors that operate based on novel mixing technologies.


    Gil Roth || April 1, 2009
    With bio-financing tight, can service providers find new models?

  • Covance Increases Biotech Service Capacity

    February 26, 2009
    Covance is expanding its biotechnology services facility in Harrogate, UK. The company also received a cGMP Manufacturing License from the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK.

  • Merck Serono To Expand Biotech Center

    November 12, 2008
    Merck Serono recently held a cornerstone ceremony at the Merck Serono Biotech Center (MSBC), its production site in Corsiersur-Vevey, Switzerland, to mark the expansion of the site. The expansion will enable the production of greater quantities of Er…

  • InNexus Biotechnology Develops New EGFR Antibody

    November 7, 2008
    InNexus Biotechnology has developed a new antibody product from its DXL platform technology, DXL1218 (EGFR), for the potential treatment of colorectal cancer.     "Recent experimental data suggests that DXL1218 (EGFR) is superi…

  • Sartorius Stedim Biotech Acquires Wave Biotech

    October 31, 2008
    Sartorius Stedim Biotech GmbH (SSB) signed an agreement to acquire the Swiss-based technology company Wave Biotech AG. The two companies have been working together since 2006 on joint research projects. SSB has been exclusively marketing Wave's pro…

  • MedImmune, SBI Biotech Enter Autoimmune Disease Research Pact

    September 12, 2008
    MedImmune, the global biologics unit of AstraZeneca, and SBI Biotech Co., Ltd, have entered into a licensing and collaboration agreement to develop and commercialize SBI Biotech's anti-ILT7 protein for the potential treatment of systemic lupus erythe…

  • Enzon To Spin Off Biotech Business

    May 8, 2008
    Enzon Pharmaceuticals, Inc. announced plans to spin off its biotechnology business into an independent company focusing on the development of cancer treatments. Enzon will fund the new company with $150 million, which is expected to provide two to th…

  • Goodwin Biotechnology Completes Expansion

    May 6, 2008
    Goodwin Biotechnology, Inc. (GBI) has completed the expansion of its cGMP manufacturing space, doubling its capacity. The expansion includes the addition of a 200L and 500L stirred tank bioreactor train to its hollow fiber and perfusion capabilities,…

  • Sartorius Stedim Biotech Signs Supply Pact

    January 16, 2008
    Sartorius Stedim Biotech’s subsidiary, Sartorius Stedim North America, has entered into an exclusive cooperation and supply agreement with Paul Mueller Co. (PMC), covering the U.S., Canada, the U.S. Virgin Islands and Puerto Rico. Sartorius Ste…

  • GPC Biotech To Restructure

    November 15, 2007
    GPC Biotech has announced plans to restructure, a process that will include layoffs of approximately 44% of the company’s current active workforce. Both the German and U.S. workforce will be cut. The company is "retaining key personnel nee…

  • GPC Biotech Restructures

    August 23, 2007
    GPC Biotech AG is restructuring and will reduce its U.S. staff by 46 employees (approximately 15%) with reductions in the commercialization, drug development and general and administrative groups. The company also announced that Martine George, M.D.…

  • GE Healthcare Acquires Wave Biotech

    April 17, 2007
    GE Healthcare, a unit of General Electric Co., has acquired Wave Biotech LLC, a supplier of disposable manufacturing technologies for the biopharmaceutical industry. The acquisition of Wave Biotech LLC, including its subsidiary Wave Europe Pvt. Ltd.,…

  • Sartorius Combines Biotech Division with Stedim

    February 22, 2007
    Sartorius AG has signed a definitive agreement with Stedim Biosystems S.A., to acquire a substantial stake in Stedim, combining its Biotechnology Division with Stedim's biopharmaceutical supply business. Upon completion of this transaction, Sartorius…

  • Crucell Receives First Wyeth Biotech Orders

    December 15, 2006
    Crucell has received its first orders for the CMO agreement with NJ-based Wyeth Biotech. The agreement for formulation and filing of a vaccine was finalized at the end of 2005 and will have the first business impact for Crucell in 2007. The vaccine w…

  • Pfizer Licenses AMD Drug from Quark Biotech

    September 26, 2006
    Pfizer and Quark Biotech have entered into an agreement under which Pfizer acquires an exclusive worldwide license to Quark's novel human gene RTP-801 and to molecules that modify its expression or function. RTP-801 is involved in the development of…

  • Biogen, mondoBIOTECH Sign License Agreement

    September 14, 2006
    Biogen Idec and mondoBIOTECH AG have signed an exclusive collaboration and license agreement for Biogen Idec to develop, manufacture and commercialize Aviptadil, a clinical compound for the treatment of Pulmonary Arterial Hypertension (PAH). Und…

  • Novozymes Acquires Delta Biotechnology

    July 7, 2006
    Novozymes acquired Delta Biotechnology, Ltd. from the Sanofi-Aventis Group as part of its strategy to extend its portfolio of products that are used as key ingredients in biopharmaceutical products. Delta, a wholly-owned subsidiary of Novozymes, oper…

  • Toxicology & Biotechnology at the Crossroads

    Toxicology & Biotechnology at the Crossroads

    Steve Barkyoumb, DVM || June 8, 2006
    Current issues in safety evaluation

  • AstraZeneca Bids on UK Biotech

    May 15, 2006
    AstraZeneca has made a bid to acquire Cambridge Antibody Technology (CAT) in a deal valued at $1.3 billion. CAT, Britain's largest biotech company, develops drugs from antibodies, the body's natural immune defence, which generally have fewer side-eff…

  • InNexus Biotech, Affirmed Therapeutics

    April 11, 2006
    InNexus Biotechnology and Affimed Therapeutics have formed a collaboration utilizing Affimed's antibodies and InNexus' SuperAntibody antibody enhancement drug development platform. The companies will complete feasibility studies and InNexus will have…

  • Japanese Biotech Opens U.S. Operations

    March 8, 2006
    The Science Center, a leading venture ecosystems for life sciences and biotechnology companies, has partnered with Aqumen Biopharmaceuticals, KK of Fukuoka, Japan to open a U.S. base for the company's operations. The partnership is part of a broader…

  • Viventia Biotech, Dowpharma Enter License Agreement

    February 14, 2006
    Viventia Biotech, Inc. and Dowpharma contract manufacturing services, a business unit of The Dow Chemical Co., have entered into a commercial license agreement for Pfenex Expression Technology, a Pseudomonas-based technology from Dowpharma. Under the…

  • There's Something About Biotech

    Faiz Kermani, Ph.D. || August 23, 2005
    Exploring the worldwide potential for Biopharma production

  • Pharma-Biotech Alliances

    Jon Hess and Elio Evangelista || August 23, 2005
    Jockeying for position in the race to become "partner of choice"